prednisolone has been researched along with Parkinson Disease in 7 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since the degree of overexpression of D3R is increased in a high dose of pramipexole, for patients with PD who are treated with L-dopa chronically, a new use of pramipexole and an increase in dose to alleviate the symptoms of PD should be implemented with caution while closely observing the occurrence of drug-induced complications such as dystonia and CRPS." | 7.85 | Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report. ( Park, D, 2017) |
| "Since the degree of overexpression of D3R is increased in a high dose of pramipexole, for patients with PD who are treated with L-dopa chronically, a new use of pramipexole and an increase in dose to alleviate the symptoms of PD should be implemented with caution while closely observing the occurrence of drug-induced complications such as dystonia and CRPS." | 3.85 | Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report. ( Park, D, 2017) |
| "A 64 year-old female with Parkinson disease treated with amantadine for two years who suddenly suffered bilateral corneal oedema." | 3.78 | [Corneal toxicity due to amantadine]. ( Avendaño-Cantos, EM; Celis-Sánchez, J; Gálvez-Martínez, J; González Del Valle, F; López-Arroquia, E; Mesa-Varona, D, 2012) |
| "Neck dystonia is the most common cause of dropped head sign in parkinsonism." | 1.37 | Dramatic response of dropped head sign to treatment with steroid in Parkinson's disease: report of three cases. ( Hemmi, S; Izawa, N; Kurokawa, K; Kutoku, Y; Murakami, T; Sunada, Y, 2011) |
| "Two patients presented with a subacute confusional state, two with dementia, and one with depression." | 1.28 | Neuropsychiatric systemic lupus erythematosus in elderly people: a case series. ( Bendall, P; Byrne, EJ; Dennis, MS; Hopkinson, N, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, D | 1 |
| Hemmi, S | 1 |
| Kurokawa, K | 1 |
| Izawa, N | 1 |
| Kutoku, Y | 1 |
| Murakami, T | 1 |
| Sunada, Y | 1 |
| Avendaño-Cantos, EM | 1 |
| Celis-Sánchez, J | 1 |
| Mesa-Varona, D | 1 |
| Gálvez-Martínez, J | 1 |
| López-Arroquia, E | 1 |
| González Del Valle, F | 1 |
| Ito, E | 1 |
| Okamoto, H | 1 |
| Mochizuki, A | 1 |
| Ohara, K | 1 |
| Kato, M | 1 |
| Terashima, Y | 1 |
| Tanaka, E | 1 |
| Takagi, K | 2 |
| Uchiyama, S | 1 |
| Iwata, M | 1 |
| Kao, KP | 1 |
| Kwan, SY | 1 |
| Lin, KP | 1 |
| Chang, YC | 1 |
| Dennis, MS | 1 |
| Byrne, EJ | 1 |
| Hopkinson, N | 1 |
| Bendall, P | 1 |
| Nagao, T | 1 |
| Hashida, H | 1 |
| Masaki, T | 1 |
| Sakuta, M | 1 |
7 other studies available for prednisolone and Parkinson Disease
| Article | Year |
|---|---|
Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Complex Regional Pain Syndromes; Dystonia; Female; Foot; | 2017 |
Dramatic response of dropped head sign to treatment with steroid in Parkinson's disease: report of three cases.
Topics: Aged; Dystonia; Electromyography; Female; Head; Humans; Magnetic Resonance Imaging; Neck Muscles; Pa | 2011 |
[Corneal toxicity due to amantadine].
Topics: Acyclovir; Amantadine; Antiparkinson Agents; Aqueous Humor; Cataract Extraction; Ceftazidime; Cornea | 2012 |
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome accompanied by Parkinson's disease.
Topics: Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Edema; Female; Foot; | 2007 |
Coexistence of Parkinson's disease and myasthenia gravis: a case report.
Topics: Brain; Cholinesterase Inhibitors; Female; Humans; Middle Aged; Myasthenia Gravis; Parkinson Disease; | 1993 |
Neuropsychiatric systemic lupus erythematosus in elderly people: a case series.
Topics: Aged; Aged, 80 and over; Azathioprine; Confusion; Dementia; Diagnosis, Differential; Drug Therapy, C | 1992 |
[A case of progressive systemic sclerosis and Sjögren's syndrome complicated by parkinsonism with special reference to the beneficial effect of corticosteroid].
Topics: Aged; Drug Resistance; Female; Humans; Levodopa; Parkinson Disease; Prednisolone; Scleroderma, Syste | 1991 |